Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor
Daniela Montagna(Centro de Neumologia Pediatrica), Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Franco Locatelli(Bambino Gesù Children's Hospital), Virginia Libri(University of Bologna), Ilaria Schiavetto(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Salvatore Siena(University of Milan), Simona Secondino(Azienda Ospedaliera Treviglio), Laura Caliogna(Policlinico San Matteo Fondazione), Rita Maccario(Policlinico San Matteo Fondazione), Andrea Pession(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Roberto Tonelli(University of Modena and Reggio Emilia), Raffaella Villa(IRCCS Policlinico San Donato), Roberta Schiavo(Azienda Unità Sanitaria Locale Piacenza), Enrica Montini(University of Pavia), Ilaria Turin(Policlinico San Matteo Fondazione)
Cited by 30
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738